jaqinus
pfizer new zealand limited - tofacitinib citrate 8.078mg equivalent to tofacitinib 5 mg - film coated tablet - 5 mg - active: tofacitinib citrate 8.078mg equivalent to tofacitinib 5 mg excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry ii white 33g28523 - treatment of the signs and symptoms of moderate to severe active rheumatoid arthritis in adults who have had an inadequate response or are intolerant to methotrexate. jaqinus can be used alone or in combination with nonbiological dmards, including methotrexate. therapy with jaqinus should be initiated and monitored by a rheumatologist or specialist physician with expertise in the management of rheumatoid arthritis.
specimen receptacle ivds
f&m family trust t/a cell biosciences - ct936 - specimen receptacle ivds - specimen receptacle ivd
comtan tablet
sandoz canada incorporated - entacapone - tablet - 200mg - entacapone 200mg - catechol-o-methyltransferase (comt) inhibitors
apo-entacapone tablet
apotex inc - entacapone - tablet - 200mg - entacapone 200mg - catechol-o-methyltransferase (comt) inhibitors
sandoz entacapone tablet
sandoz canada incorporated - entacapone - tablet - 200mg - entacapone 200mg - catechol-o-methyltransferase (comt) inhibitors
auro-entacapone tablet
auro pharma inc - entacapone - tablet - 200mg - entacapone 200mg - catechol-o-methyltransferase (comt) inhibitors
pramosone- hydrocortisone acetate and pramoxine hydrochloride cream
sebela pharmaceuticals inc. - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj), pramoxine hydrochloride (unii: 88ayb867l5) (pramoxine - unii:068x84e056) - hydrocortisone acetate 25 mg in 1 g - indications and usage: topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. contraindications: topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
winrho (d) immune globulin liquid
cangene biopharma, llc - human immunoglobulin g (unii: 66y330cjhs) (human immunoglobulin g - unii:66y330cjhs) - human immunoglobulin g 600 [iu] in 1 ml
kedbumin (albumin- human injection, solution
kedrion s.p.a - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin (human) 12.5 g in 50 ml - for restoration and maintenance of circulating blood volume where volume deficiency is demonstrated and colloid use is appropriate. kedbumin® is indicated for severe albumin deficiency caused by illness or active bleeding. when albumin deficiency results from excessive protein loss, the effect of albumin administration will be temporary unless the underlying disorder is reversed. kedbumin® is indicated for maintenance of cardiovascular function following the removal of large volumes of ascitic fluid due to cirrhosis [1, 2]. kedbumin® is indicated as a plasma expander in the fluid management of severe forms of ovarian hyperstimulation syndrome (ohss) [3, 4]. kedbumin® is indicated in conjunction with diuretics to correct fluid volume overload associated with ards [5]. kedbumin® is indicated after > 24 hours post burn in patients experiencing severe albumin depletion in order to favor edema re-absorption [6]. kedbumin® is indicated in patients undergoing long term dialysis or for those patients who are fl
ic-green- indocyanine green injection, powder, lyophilized, for solution
novadaq technologies, inc. - indocyanine green (unii: ix6j1063hv) (indocyanine green acid form - unii:c4v974v932) - indocyanine green 25 mg - for determining cardiac output, hepatic function and liver blood flow, and for ophthalmic angiography. ic‑green™ contains sodium iodide and should be used with caution in patients who have a history of allergy to iodides.